Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
09/06/2012 | US20120225793 Methods for identifying, diagnosing, and predicting survival of lymphomas |
09/06/2012 | US20120225788 Topoisomerase Binding Probe and Method of Use |
09/06/2012 | US20120225786 Risk variants for cancer |
09/06/2012 | US20120225497 Zwitterion-containing acridinium compounds |
09/06/2012 | US20120225496 Organic colored microparticles, diagnostic reagent kit containing the same, and in vitro diagnosis method |
09/06/2012 | US20120225494 Dna ligands for aflatoxin and zearalenone |
09/06/2012 | US20120225493 Electronic-Chemometric Controlled System and Process for the Analysis of Analytes |
09/06/2012 | US20120225492 Starch Binding Domain and Use Thereof |
09/06/2012 | US20120225488 Particulate measurement system |
09/06/2012 | US20120225486 Diagnosis and assessment of skeletal related disease using calcium 41 |
09/06/2012 | US20120225482 Mammalian cx3c chemokine antibodies |
09/06/2012 | US20120225478 Anti-amyloid beta antibodies and their use |
09/06/2012 | US20120225443 Stabilized standards for busulfan immunoassay |
09/06/2012 | US20120225442 New Markers for the Diagnosis of Celiac Disease |
09/06/2012 | US20120225441 Protein markers for detecting liver cancer and method for identifying the markers thereof |
09/06/2012 | US20120225440 Hepatocellular carcinoma protein marker, and method for detection of hepatocellular carcinoma using the same |
09/06/2012 | US20120225439 Protein markers for detecting liver cancer and method for identifying the markers thereof |
09/06/2012 | US20120225438 Systems and methods for detecting animal pregnancy |
09/06/2012 | US20120225437 Methods for identifying inhibitors of mannan-binding lectin associated serine protease (masp) proteins and uses thereof |
09/06/2012 | US20120225436 Immuno-Based Botulinum Toxin Serotype A Activity Assays |
09/06/2012 | US20120225435 Nanopipette apparatus for manipulating cells |
09/06/2012 | US20120225433 Gene Expression Markers for Breast Cancer Prognosis |
09/06/2012 | US20120225432 Method and Kit for the Prognosis of Mantle Cell Lymphoma |
09/06/2012 | US20120225430 Methods for detecting human papilloma virus-associated cancers |
09/06/2012 | US20120225426 Baalc expression as a diagnostic marker for acute leukemia |
09/06/2012 | US20120225425 Cathepsin E as a Marker of Colon Cancer |
09/06/2012 | US20120225423 Pathogen detection biosensor |
09/06/2012 | US20120225422 Method and device employing a non-receptor ligand interaction with nanoparticles or other solid phase followed by specific detection |
09/06/2012 | US20120225170 Device for detecting the internal temperature of a foodstuff |
09/06/2012 | US20120225124 Stable laquinimod preparations |
09/06/2012 | US20120225078 Immune system modulating composition |
09/06/2012 | US20120225077 Novel molecules of the card-related protein family and uses thereof |
09/06/2012 | US20120225073 Isolation and Use of Melanoma Cancer Stem Cells |
09/06/2012 | US20120225072 Stable formulations of immunoglobulin single variable domains and uses thereof |
09/06/2012 | US20120225068 Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza a (h1n1) virus (s-oiv) infections |
09/06/2012 | US20120225059 Novel Agents and Uses Thereof |
09/06/2012 | US20120225042 Competitive exclusion composition and methods |
09/06/2012 | US20120225021 Stable colloidal gold nanoparticles with controllable surface modification and functionalization |
09/06/2012 | US20120225013 Anti-mesothelin antibodies and immunoconjugates |
09/06/2012 | US20120224996 Stack of test strips and method for the production thereof |
09/06/2012 | US20120223260 Method and a system for determination of particles in a liquid sample |
09/06/2012 | US20120222959 Pinching channels for fractionation of fragmented samples |
09/06/2012 | US20120222773 Analyzer and position confirming method |
09/06/2012 | US20120222468 Attachment device for identifying constituents within a fluid |
09/06/2012 | US20120222467 Measuring device |
09/06/2012 | DE202012007351U1 Feldprüfgerät zur Bestimmung von Verformungskennwerten von Asphaltflächen Feldprüfgerät for the determination of deformation characteristics of asphalt surfaces |
09/06/2012 | DE112009005237T5 Verfahren zum nachweisen von autodigestion A method for detecting autodigestion |
09/05/2012 | EP2495570A1 Measurement system, measurement method, program for executing aforementioned method, and recording medium of said program |
09/05/2012 | EP2495569A1 Method for determination of sensitivity to anti-cancer agent |
09/05/2012 | EP2495568A1 Method for determining sensitivity to an anticancer agent |
09/05/2012 | EP2495567A1 Methods and means for monitoring disruption of tissue homeostasis in the total body |
09/05/2012 | EP2495566A1 Il-22 as a prognostic and diagnostic marker in rheumatoid arthritis |
09/05/2012 | EP2495565A1 Method for assaying component to be assayed in specimen and assay kit |
09/05/2012 | EP2495564A1 5.9 kDa PEPTIDE IMMUNOASSAY METHOD |
09/05/2012 | EP2495563A1 Diagnostic agent for infectious diseases |
09/05/2012 | EP2495561A1 Anticancer agent sensitivity-determining marker |
09/05/2012 | EP2495555A1 Measuring device |
09/05/2012 | EP2495551A1 Method for analyzing and detecting calcium element in ore |
09/05/2012 | EP2495547A1 Detecting ethanol and water concentration in fuel |
09/05/2012 | EP2495545A2 Method for determining the porosity of layers and use of the method to determine adhesive tensile strength |
09/05/2012 | EP2495542A1 Fuel property detection device for construction equipment and construction equipment provided therewith |
09/05/2012 | EP2495338A1 Use of phenanthridium derivatives for distinguishing between intact and membrane-compromised cells using molecular nucleic acid-based techniques |
09/05/2012 | EP2495334A1 Method for detection of target nucleic acid |
09/05/2012 | EP2495333A1 Method for producing a test element for investigating a bodily fluid sample and test element |
09/05/2012 | EP2495331A1 Testing method for drug sensitivity of mycobacterium tuberculosis, application of indicator and solid medium |
09/05/2012 | EP2495327A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
09/05/2012 | EP2495324A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
09/05/2012 | EP2495319A1 INTEGRIN alpha8beta1-SPECIFIC MONOCLONAL ANTIBODY |
09/05/2012 | EP2494980A2 Medical utility of glycans |
09/05/2012 | EP2494922A2 Processing analyte sensor data |
09/05/2012 | EP2494921A2 Processing analyte sensor data |
09/05/2012 | EP2494920A1 Medical device capable of measuring a blood glucose level containing a data projector |
09/05/2012 | EP2494874A1 Control of flavor characteristics of fruit juice |
09/05/2012 | EP2494365A2 Covalent attachment of peptides and biological molecules to luminescent semiconductor nanocrystals |
09/05/2012 | EP2494364A1 Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes |
09/05/2012 | EP2494363A1 Method of predicting risk of preterm birth |
09/05/2012 | EP2494362A2 Prostate tumor markers and methods of use thereof |
09/05/2012 | EP2494361A1 Ovary tumor markers and methods of use thereof |
09/05/2012 | EP2494360A2 Diagnostic methods for determining prognosis of non-small cell lung cancer |
09/05/2012 | EP2494359A1 Podxl protein in colorectal cancer |
09/05/2012 | EP2494358A1 Method for the direct measure of molecular interactions by detection of light reflected from multilayered functionalized dielectrics |
09/05/2012 | EP2494357A1 Composition, device and method for colorimetric detection of an analyte using imprinted polymers and photochromic switch molecules |
09/05/2012 | EP2494356A1 Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis |
09/05/2012 | EP2494355A1 Pcsk9 immunoassay |
09/05/2012 | EP2494354A1 Pcsk9 immunoassay |
09/05/2012 | EP2494353A2 Microvessels, microparticles, and methods of manufacturing and using the same |
09/05/2012 | EP2494352A1 Assays for the detection of anti-tnf drugs and autoantibodies |
09/05/2012 | EP2494351A1 Colon and rectal tumor markers and methods of use thereof |
09/05/2012 | EP2494350A1 Antagonists and agonists of bitter taste receptors and uses thereof |
09/05/2012 | EP2494349A1 Genes, methods, and compositions related to neurogenesis and its modulation |
09/05/2012 | EP2494348A1 Method and system for determining the quality of the atmosphere of an inside environment |
09/05/2012 | EP2494347A1 Electrochemical sensors including electrodes with diffusion barriers |
09/05/2012 | EP2494342A1 Combustible gas sensors including integral support structures and combustible gas sensor with multiple active elements |
09/05/2012 | EP2494080A1 Method for screening nucleic acid ligand |
09/05/2012 | EP2494077A2 Molecular profiling for personalized medicine |
09/05/2012 | EP2494074A1 Methods for diagnosing irritable bowel syndrome |
09/05/2012 | EP2494064A1 A proximity ligation assay involving generation of catalytic activity |
09/05/2012 | EP2494034A2 Human omental mesothelial cells, methods of isolation and uses thereof |
09/05/2012 | EP2493917A1 Breast tumor markers and methods of use thereof |
09/05/2012 | EP2493916A1 Lung tumor markers and methods of use thereof |